Alnylam Pharmaceuticals | ALNY - Выручка от реализации

Биржевая цена
301.30
Изменение за день
-0.81 -0.27%
Ежемесячно
-4.68%
Ежегодный
14.46%
Q2 прогноз
299.00




Продажи Изменить Дата
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amgen USD 9.9B 340M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Incyte USD 1.27B 240M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Moderna USD 678M 342M 2025-12
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.11B 750M 2026-03
PTC Therapeutics USD 164.7M 46.3M 2025-12
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 12.14B 65M 2026-03
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Takeda JPY 1.19T 80B 2025-12
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Xencor USD 28.24M 7.24M 2025-12